These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38357945)

  • 1. A Novel KIF4A-Related Model for Predicting Immunotherapy Response and Prognosis in Kidney Renal Clear Cell Carcinoma.
    Yang GH; Ma XD; Wei XF; Liu RL; Wang C
    Comb Chem High Throughput Screen; 2024 Feb; ():. PubMed ID: 38357945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma.
    Zhang M; Liu YF; Gao Y; Zhao C; Chen M; Pan KH
    Transl Oncol; 2023 Aug; 34():101693. PubMed ID: 37315507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necroptosis-related genes are associated with prognostic features of kidney renal clear cell carcinoma.
    Wang Y; Pan KH; Chen M
    Discov Oncol; 2023 Oct; 14(1):192. PubMed ID: 37878133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma.
    Li C; Chen J; Su Z
    Transl Cancer Res; 2020 Nov; 9(11):7165-7173. PubMed ID: 35117320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma.
    Shen Y; Cao Y; Zhou L; Wu J; Mao M
    Front Mol Biosci; 2022; 9():928006. PubMed ID: 36120545
    [No Abstract]   [Full Text] [Related]  

  • 7. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
    Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
    Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic Analysis on the Prognostic Value of Neurotransmitter Receptor-Related Genes in Kidney Renal Clear Cell Carcinoma.
    Zhang H; Wang N; Yu T; Li Q; Yang L; Su Y; Wang P; Liu J; Yang L; Zhang J
    Altern Ther Health Med; 2023 Nov; 29(8):356-365. PubMed ID: 37632962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma.
    Xia QD; Li B; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Zhang YC; Guan W; Li H; Wang SG
    Front Oncol; 2023; 13():1096341. PubMed ID: 37035135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
    Liu S; Yu Y; Wang Y; Zhu B; Han B
    Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
    Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
    Front Immunol; 2022; 13():934387. PubMed ID: 35958561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.
    Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid metabolism-related genes as a novel module biomarker for kidney renal clear cell carcinoma: Bioinformatics modeling with experimental verification.
    Jia Z; Fu Z; Kong Y; Wang C; Zhou B; Lin Y; Huang Y
    Transl Oncol; 2023 Dec; 38():101774. PubMed ID: 37708719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
    Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
    Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
    Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
    Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
    Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.